These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 29916183)
21. Involvement of cAMP/cAMP-dependent protein kinase signaling pathway in regulation of Na+,K+-ATPase upon activation of opioid receptors by morphine. Wu ZQ; Li M; Chen J; Chi ZQ; Liu JG Mol Pharmacol; 2006 Mar; 69(3):866-76. PubMed ID: 16317112 [TBL] [Abstract][Full Text] [Related]
22. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Noble F; Cox BM Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358 [TBL] [Abstract][Full Text] [Related]
23. MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway. Ai W; Gong J; Yu L FEBS Lett; 1999 Jul; 456(1):196-200. PubMed ID: 10452557 [TBL] [Abstract][Full Text] [Related]
24. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein. Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558 [TBL] [Abstract][Full Text] [Related]
25. Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. Shoblock JR; Maidment NT Neuropsychopharmacology; 2006 Jan; 31(1):171-7. PubMed ID: 15956992 [TBL] [Abstract][Full Text] [Related]
26. [Effects of long-term morphine exposure on the cAMP system and c-Fos phosphorylation in differentiated SH-SY5Y cells]. Fang F; Cao Q; Song F; Liu J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):262-7. PubMed ID: 12567447 [TBL] [Abstract][Full Text] [Related]
27. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. Chartoff EH; Papadopoulou M; Konradi C; Carlezon WA J Neurochem; 2003 Oct; 87(1):107-18. PubMed ID: 12969258 [TBL] [Abstract][Full Text] [Related]
28. Effect of chronic treatment of ohmefentanyl stereoisomers on cyclic AMP formation in Sf9 insect cells expressing human mu-opioid receptors. Liu ZH; He Y; Jin WQ; Chen XJ; Shen QX; Chi ZQ Life Sci; 2004 Apr; 74(24):3001-8. PubMed ID: 15051423 [TBL] [Abstract][Full Text] [Related]
29. Chronic morphine treatment increases stimulatory beta-2 adrenoceptor signaling in A431 cells stably expressing the mu opioid receptor. Ammer H; Schulz R J Pharmacol Exp Ther; 1997 Jan; 280(1):512-20. PubMed ID: 8996236 [TBL] [Abstract][Full Text] [Related]
30. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence. Wells JL; Bartlett JL; Ananthan S; Bilsky EJ J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048 [TBL] [Abstract][Full Text] [Related]
31. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732 [TBL] [Abstract][Full Text] [Related]
32. Supersensitization of the adenylyl cyclase system in Chinese hamster ovary cells co-expressing cloned opioid receptors and Gz, a PTX-insensitive G protein. Ozawa T; Nakagawa T; Minami M; Satoh M Neurosci Lett; 1999 May; 267(2):117-20. PubMed ID: 10400226 [TBL] [Abstract][Full Text] [Related]
33. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Ammon S; Mayer P; Riechert U; Tischmeyer H; Höllt V Brain Res Mol Brain Res; 2003 Apr; 112(1-2):113-25. PubMed ID: 12670709 [TBL] [Abstract][Full Text] [Related]
34. Naloxone-precipitated withdrawal jumping in 11 inbred mouse strains: evidence for common genetic mechanisms in acute and chronic morphine physical dependence. Kest B; Palmese CA; Hopkins E; Adler M; Juni A; Mogil JS Neuroscience; 2002; 115(2):463-9. PubMed ID: 12421612 [TBL] [Abstract][Full Text] [Related]
35. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice. Crain SM; Shen KF Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296 [TBL] [Abstract][Full Text] [Related]
36. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence. Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618 [TBL] [Abstract][Full Text] [Related]
37. Comparison of agmatine with moxonidine and rilmenidine in morphine dependence in vitro: role of imidazoline I(1) receptors. Li F; Wu N; Su RB; Liu Y; Lu XQ; Li J Eur J Pharmacol; 2009 Jun; 612(1-3):1-8. PubMed ID: 19356733 [TBL] [Abstract][Full Text] [Related]
38. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes. Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Vogel Z Neuropharmacology; 2000 Jan; 39(3):364-71. PubMed ID: 10698002 [TBL] [Abstract][Full Text] [Related]
39. MiR-582-5p/miR-590-5p targeted CREB1/CREB5-NF-κB signaling and caused opioid-induced immunosuppression in human monocytes. Long X; Li Y; Qiu S; Liu J; He L; Peng Y Transl Psychiatry; 2016 Mar; 6(3):e757. PubMed ID: 26978739 [TBL] [Abstract][Full Text] [Related]
40. Morphine and endomorphins differentially regulate micro-opioid receptor mRNA in SHSY-5Y human neuroblastoma cells. Yu X; Mao X; Blake AD; Li WX; Chang SL J Pharmacol Exp Ther; 2003 Aug; 306(2):447-54. PubMed ID: 12754318 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]